Figure | Panel | Data structure | Test type | p value |
---|---|---|---|---|
1 | P | Normally distributed | One-way ANOVA | <0.0001 |
1 | Q | Normally distributed | One-way ANOVA | <0.0001 |
1 | R | Normally distributed | One-way ANOVA | <0.0001 |
1 | S | Normally distributed | One-way ANOVA | <0.0001 |
1 | T | Normally distributed | One-way ANOVA | <0.0001 |
3 | A | Normally distributed | Two-way RM ANOVA | 0.0002 |
4 | A | Normally distributed | Two-way RM ANOVA | 0.0012 |
4 | B | Normally distributed | Two-way RM ANOVA | 0.3361 |
4 | C | Normally distributed | Two-way RM ANOVA | 0.0297 |
4 | D | Normally distributed | Two-way RM ANOVA | 0.7184 |
5 | A | Normally distributed | Two-way RM ANOVA | 0.2709 |
5 | B | Normally distributed | Two-way RM ANOVA | 0.4094 |
5 | C | Normally distributed | Two-way RM ANOVA | 0.0012 |
5 | D | Normally distributed | Two-way RM ANOVA | 0.0106 |
6 | A | Normally distributed | Two-way RM ANOVA | 0.4819 |
6 | B | Normally distributed | Two-way RM ANOVA | 0.8865 |
7 | A Vehicle ZT2 | Normally distributed | Linear regression | 0.0741 |
7 | B Dexamethasone ZT2 | Normally distributed | Linear regression | 0.6525 |
7 | A Fludrocortisone ZT2 | Normally distributed | Linear regression | 0.4217 |
7 | B Mifepristone ZT2 | Normally distributed | Linear regression | 0.6743 |
7 | A Eplerenone ZT2 | Normally distributed | Linear regression | 0.0318 |
7 | C Vehicle ZT10 | Normally distributed | Linear regression | 0.1518 |
7 | D Dexamethasone ZT10 | Normally distributed | Linear regression | 0.242 |
7 | C Fludrocortisone ZT10 | Normally distributed | Linear regression | 0.504 |
7 | D Mifepristone ZT10 | Normally distributed | Linear regression | 0.4581 |
7 | C Eplerenone ZT10 | Normally distributed | Linear regression | 0.9576 |
8 | A | Normally distributed | Two-way RM ANOVA | 0.0005 |
8 | B | Normally distributed | Two-way RM ANOVA | 0.003 |